Open enrollment doesn't have to determine your GLP-1 timeline.
eMed's GLP-1 program isn't dependent on open enrollment — giving employers the flexibility to implement outside the traditional benefits cycle.
There's a time to get started
Every workforce is different. eMed offers flexible plans built to fit your population, your priorities, and your bottom line, on your timeline, not open enrollment's.
Situation
Obesity is already on your books.
Whether you cover GLP-1s or not, obesity already costs employers millions in claims, absenteeism and lost productivity.
The bill is just hiding in different line items.
Annual employer burden
$425B
Combined cost of obesity and overweight on U.S. employers in 2023 — medical, absenteeism, and presenteeism.
Nature / Nutrition & Diabetes 2024
Higher medical costs
2x
Employees with severe obesity incur more than double the annual medical costs of healthy-weight colleagues.
American Journal of Health Promotion
more absenteeism
2.28x
Employees struggling with obesity miss significantly more workdays than healthy-weight colleagues.
JOEM
You’ve got GLP-1 coverage challenges. eMed has solutions.
For benefits leaders evaluating GLP-1 solutions, doesn't have to set the clock. eMed's program can be implemented outside the traditional enrollment period, giving you greater flexibility around when you introduce it to your workforce.
Lower Cost
Reduce clinical cost of care and get direct pricing on FDA-approved medications with no PBM markups, no rebate inflation and no surprises.
More Control
You set the employee contribution. You manage utilization. You own the outcome.
High Adherence
At-home diagnostics, 24/7 support and ongoing progress tracking keeps members coming back.
Guaranteed Outcomes
We guarantee employee weight loss and adherence. If we miss, you pay less.
PROVEN OUTCOMES
Industry leading adherence. Real results. Measured from day one.
Reduction in prediabetes risk
Among members with HbA1C > 5.7-6.4% at enrollment
Drop in high triglycerides
Among members at >150 mg/dL at enrollment
Reduction in high cholesterol
Among members at >200 mg/dL at enrollment
Average weight lost per member
Starting average: 220.4 lbs
Matched lab data from Dec 2025, Internal eMed Corporate Partner Data.
Source: Aon Workforce-Focused Analysis on GLP-1s, Phase Two Findings; January 13, 2026
*Among matched lab cohort participants with available data, observed reduction in the proportion with HbA1c above 5.7% over the measurement period. Individual results vary. Outcomes are not guaranteed.
What others are saying about eMed
"When you see the benefits GLP-1 medications bring to the people you work with every day, it underscores how the decisions employers make today shape the future of colleague health, wellbeing and productivity and drive sustainable business performance and growth.”
Lisa Stevens
Chief People and Administrative Officer
.avif){kind=logo}
If a GLP-1 strategy is still on your benefits roadmap, you don't have to wait until next year to act.
